Navigation Links
Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders
Date:2/9/2011

RESEARCH TRIANGLE PARK, N.C., Feb 9, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR) announced today the webcast and teleconference information for its special meeting of shareholders, to be held on February 14, 2011 at 3:30 p.m. Eastern Time at the Research Triangle Park Marriott, 4700 Guardian Drive, Durham, North Carolina 27703. Shareholders at the meeting will vote on the previously announced merger agreement under which Grifols (GRF.MC) will acquire TLCR.

Investors and analysts may participate in a listen-only mode by calling 1-888-713-4199 (domestic) or 1-617-213-4861 (international) and entering passcode number 93263113. To ensure timely access, please dial into the call approximately 10 minutes prior to it start time. The listen-only webcast will also be available through the Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.


'/>"/>
SOURCE Talecris Biotherapeutics Holdings Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Talecris Biotherapeutics to Report Fourth Quarter and Full Year 2010 Financial Results
2. Talecris Biotherapeutics Announces Revised Record Date and Meeting Date for Special Meeting of Shareholders
3. Talecris Biotherapeutics Announces Jury Verdict in Contract Dispute
4. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
5. Talecris Biotherapeutics to Report Second Quarter 2010 Financial Results
6. Talecris Biotherapeutics Announces Premerger HSR Filing
7. Lafmin Morgan Joins Talecris Biotherapeutics as Vice President, U.S. Product Management
8. Talecris Names John Perkins as Executive Vice President, Global Commercial Operations
9. Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference
10. Talecris Added to NASDAQ Biotechnology Index
11. Talecris Biotherapeutics to Present at the Bank of America Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... protein research tools, announced the acquisition of GenWay ... with a comprehensive service and product offering for ... "This acquisition will facilitate growth and enhance capabilities ... proteins, antibodies, and ELISA assays will nicely complement ...
(Date:2/22/2017)... 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics ... biopharmaceutical products for companion animals, will host a live conference ... to discuss financial results from the fourth quarter and full ... and investors may access the audio webcast or ... ...
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. ... be presenting at the Annual Biocom Global Life Science ... 2, at 11:15 AM, at the Torrey Pines Lodge, ... to the organizers at Biocom who have chosen our ... symposium of biotechnology companies, investors, and clinical researchers," said ...
(Date:2/22/2017)... ON (PRWEB) , ... February 22, 2017 , ... ... on discovery and development of precision treatments for neurodegenerative diseases, today announced it ... validate the ProMIS approach.” This is one of a series of commentaries from ...
Breaking Biology Technology:
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm ... of the laboratory use of nuclear magnetic resonance ... experienced end-users and profiled current practices, developments, trends ... as well as growth and opportunities. These areas ... suppliers, NMR instruments, needs and innovation requirements, hyphenated ...
(Date:1/19/2017)... , January 19, 2017 According to a new ... and Forecast, 2014 - 2022," the global biometric sensor market is expected to ... to 2022. In 2015, Asia-Pacific dominated the global market ... private sectors. Continue Reading ... ...
Breaking Biology News(10 mins):